Freestone Capital Holdings, LLC

Q2 2020 13F-HR Detailed Holdings

Location
Seattle, WA
Holdings as of
6/30/2020
Date filed
8/4/2020
Form type
13F-HR
Num holdings
349
Total value ($000)
$8,529,782
Net value change ($000)
+3,905,882 (84.5%)
New positions
38
Sold out positions
62
Turnover %
2.1%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q1 2020
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
RDFN 2,495,117 1052.3%
SPY 1,078,232 1183.0%
DOCU 417,514 12826.9%
CWI 26,220 11063.3%
IVV 24,137 1124.2%
GLW 12,963 NEW
EFA 12,588 1230.5%
AMZN 11,297 50.2%
AAPL 11,038 58.2%
VOO 10,437 49.4%
Top Reduces (Value $000, Stocks/ETFs)
MSFT -184,068 -6.4%
SMARTSHEET INC -82,891 -99.2%
SNN -35,872 -100.0%
PXH -34,701 -95.9%
SPHD -32,732 -97.2%
BP -25,124 -97.2%
KKR -23,560 -100.0%
AIY -11,212 -70.4%
OR -11,171 -100.0%
YRI -11,001 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 109,620 (1.3% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 FREESTONE CAPITAL MANAGEMENT LLC 028-05975